Stocks
State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETFXBI

NYSE ARCAHealthcareBiotechnology$156.82-0.64%

Price as of · delayed, not real-time

This ETF tracks the S&P Biotechnology Select Industry Index, providing exposure to U.S. biotechnology companies. It is widely followed by investors seeking targeted access to high-growth potential in biotech innovation and drug development.

Market Cap: $6.3B52W Range: $92.64-$169.89

Congressional Interest in State Street SPDR S&P Biotech ETF (XBI)

12 members of Congress have disclosed 26 trades in State Street SPDR S&P Biotech ETF (XBI), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 15 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
26
Unique Politicians
12
Buys
11
Sells
15

Who in Congress Is Trading XBI?

2024-10-18$50K-$100K
ETF
2024-07-15$100K-$250K
ETF
2023-10-19$1K-$15K
ETF
2023-06-30$15K-$50K
Stock
2022-04-05$1K-$15K
ETF
2022-03-01$1K-$15K
ETF
2019-09-30$15K-$50K
Stock
2018-12-31$15K-$50K
Stock
2018-12-12$15K-$50K
ETF
2018-03-09$1K-$15K
Stock
2017-08-21$1K-$15K
ETF
2017-06-19$1K-$15K
Stock
2017-03-06$1K-$15K
Stock
2017-02-23$1K-$15K
Stock
2017-02-17$1K-$15K
ETF
2017-01-09$1K-$15K
ETF
2016-01-26$15K-$50K
ETF
2016-01-13$15K-$50K
ETF
2015-10-02$15K-$50K
ETF
2012-08-02$1K-$15K
Stock
2012-05-10$1K-$15K
Stock
2010-05-12$1K-$15K
Stock
2010-01-02$6,270.01
Stock
2009-10-08$841.99
Stock
2006-02-10$1K-$15K
Stock
2002-08-12$1K-$15K
Stock